Tag Archives | Stockholm Cancer Congress

Alpharadin may change standard of care for prostate cancer patients with bone mets

We recently attended the 2011 European Multidisciplinary Cancer Congress in Stockholm. Paradigm shifting data in breast cancer and advanced prostate cancer were presented at what turned out to be an excellent meeting in a charming, if expensive, city. Sally Church (@MaverickNY) live tweeted several sessions from the meeting and was name the “Top Twitter Influencer” […]

Continue Reading

Vismodegib best abstract at ECCO 2011 Stockholm Cancer Congress

Next week sees the start of the 2011 Stockholm Cancer Congress – a joint multidisciplinary meeting of ECCO, ESMO and ESTRO. What’s likely to be hot news from Stockholm? On Biotech Strategy Blog, Pieter Droppert has highlighted the phase III data to be presented at ECCO 2011 on Alpharadin (radium-223 chloride) in castration-resistant prostate cancer […]

Continue Reading

ECCO ESMO Stockholm Cancer Conference September 2011

Summer is almost over, and thoughts at Icarus Consultants are now turning to forthcoming medical meetings that we will be attending. Photo: Max Anderson We will be at ECCO 16 – ESMO 36 in Stockholm from September 23 – 27, 2011. The jointly organized multidisciplinary cancer congress of the European CanCer Organisation (ECCO ) and […]

Continue Reading